THORACIC SURGERY / CLINICAL RESEARCH
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Non-specific pleuritis (NSP) is a fibrinous or inflammatory pleurisy that is not attributable to a benign or malign etiology. The long-term follow-up results of patients diagnosed with NSP following video-assisted thoracoscopic surgery (VATS) were investigated in this study.

Material and methods:
This investigation focused on 593 patients with exu­dative pleural effusion who underwent VATS between 2011 and 2014. Of the 137 patients diagnosed with NSP, a total of 39 patients were excluded from the study.

Results:
Out of the 98 patients, 78 were male (80%) with their mean age being 52.2 ±15.9 years. The mean follow-up period was 1919 ±744 days. Of these patients, 70 (71.4%) had no specific diagnosis, while 28 patients (28.6%) did have specific diagnoses. Malignancy was detected in seven (7.1%) of those with specific diagnoses, with most of the diagnoses of malignancy detected within the first 36 months. Malignant diseases included mesothelioma (n = 2), lung cancer (n = 2), chronic lymphocytic leukemia (n = 1), soft tissue sarcoma (n = 1), and multiple myeloma (n = 1). Chest radiographs of malignant patients showed that statistically significantly larger amounts of fluid (40% vs. 6.9%, p = 0.026), pleural plaque (20% vs. 1.1%, p = 0.020) and nodules (20% vs. 7.7%, p = 0.020) were detected compared to patients with a benign course.

Conclusions:
Most patients diagnosed with NSP after VATS had a benign disease course. There was a probability of malignancy, although it was low. Meso­thelioma and other malignancies could be seen within the first 36 months after the biopsy. Apart from mesothelioma, other malignancies should also be considered, and further follow-up recommended for patients with a large amount of fluid, plaque and nodules found in the initial VATS images.
REFERENCES (34)
1.
Hooper C, Lee YC, Maskell N. Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65: ii4-17.
 
2.
Light RW, Lee YCG (eds.). Textbook of Pleural Diseases. Boca Raton: CRC Press, Taylor and Francis Group; 2016.
 
3.
Fishman AP, Elias JA, Fishman JA, Grippi MA, Senlor RM, Pack AI (eds.). Fishman’s Pulmonary Diseases and Disorders. New York: Mc Graw-Hill Education; 2008.
 
4.
Light RW, Rogers JT, Moyers JP, et al. Prevalence and clinical course of pleural effusions at 30 days after coronary artery and cardiac surgery. Am J Respir Crit Care Med 2002; 166: 1567-71.
 
5.
Maskell NA. Undiagnosed pleural effusions. In: Light RW, Gary Lee YC (eds.). Textbook of Pleural Diseases. 2th ed. London: CRC Press, Taylor and Francis Group; 2008, pp. 491-8.
 
6.
Boutin C, Viallat JR, Cargnino P, Farisse P. Thoracoscopy in malignant pleural effusions. Am Rev Resp Dis 1981; 124: 588-92.
 
7.
Shojaee S, Lee HJ. Thoracoscopy: medical versus surgical – in the management of pleural diseases. J Thorac Dis 2015; 7: 339-51.
 
8.
Medford AR, Awan YM, Marchbank A, Rahamim J, Unsworth-White J, Pearson PJ. Diagnostic and therapeutic performance of video-assisted thoracoscopic surgery (VATS) in investigation and management of pleural exudates. Ann R Coll Surg Engl 2008; 90: 597-600.
 
9.
Hazelrigg SR, Nunchuck SK, LoCicero J 3rd. Video assisted thoracic surgery study group data. Ann Thorac Surg 1993; 56: 1039-43.
 
10.
Salm SA. The pleura. Am Rev Respir Dis 1988; 138: 184-234.
 
11.
Janssen J, Maldonado F, Metintas M. What is the significance of non-specific pleuritis? A trick question. Clin Respir J 2018; 12: 2407-10.
 
12.
Yang T, Wu YB, Wang Z, et al. Long-term outcome of patients with nonspecific pleurisy at medical thoracoscopy. Respir Med 2017; 124: 1-5.
 
13.
Janssen JP, Ramlal S, Mravunac M. The long-term follow- up of exudative pleural effusion after nondiagnostic thoracoscopy. J Bronchol 2004; 11: 169-74.
 
14.
Davies HE, Nicholson JE, Rahman NM, Wilkinson EM, Davies RJ, Lee YC. Outcome of patients with nonspecific pleuritis/fibrosis on thoracoscopic pleural biopsies. Eur J Cardiothorac Surg 2010; 38: 472-7.
 
15.
DePew ZS, Verma A, Wigle D, Mullon JJ, Nichols FC, Maldonado F. Nonspecific pleuritis: optimal duration of follow-up. Ann Thorac Surg 2014; 97: 1867-71.
 
16.
Ferrer JS, Muñoz XG, Orriols RM, Light RW, Morell FB. Evolution of idio-pathic pleural effusion: a prospective, long-term follow-up study. Chest 1996; 109: 1508-13.
 
17.
Ryan CJ, Rodgers RF, Unni KK, Hepper NG. The outcome of patients with pleural effusion of indeterminate cause at thoracotomy. Mayo Clin Proc 1981; 56: 145-49.
 
18.
Karpathiou G, Anevlavis S, Tiffet O, et al. Clinical long-term outcome of non-specific pleuritis (NSP) after surgical or medical thoracoscopy. J Thorac Dis 2020; 12: 2096-104.
 
19.
Metintas M, Ak G, Cadirci O, Yildirim H, Dundar E, Metintas S. Outcome of patients with fibrinous pleuritis after medical thoracoscopy. Respir Med 2012; 106: 1177-83.
 
20.
Akl Y, Kaddah S, Abdelhafeez A, Salah R, Lotayef M. Epidemiology of mesothelioma in Egypt. A ten-year (1998-2007) multicentre study. Arch Med Sci 2010; 6: 926-31.
 
21.
Leslie WK, Kinasewitz CT. Clinical characteristics of the patients with nonspecific pleuritis. Chest 1988; 94: 603-8.
 
22.
Kim NJ, Hong SC, Kim JO, Suhr JW, Kim SY, Ro HK. Etio­logic considerations of nonspecific pleuritis. Korean. J Intern Med 1991; 6: 58-63.
 
23.
Venekamp LN, Velkeniers B, Noppen M. Does ‘idiopathic pleuritis’ exist? Natural history of non-specific pleuritis diagnosed after thoracoscopy. Respiration 2005; 72: 74-8.
 
24.
Cagle PT, Allen TC. Pathology of the pleura: what the pulmonologists need toknow. Respirology 2011; 16: 430-8.
 
25.
Al-Izzi M, Thurlow NP, Corrin B. Pleural mesothelioma of connective tissue type, localized fibrous tumour of the pleura, and reactive submesothelial hyperplasia. An immunohistochemical comparison. J Pathol 1989; 158: 41-4.
 
26.
Coppola A, Ghinassi G, Ciarleglio G, et al. Pleural effusion as first extra-medullary clinical presentation of an occult multiple myeloma: the role of medical thoracoscopy. Respir Med Case Rep 2020; 29: 101013.
 
27.
Ahmed S, Siddiqui AK, Rossoff L, Sison CP, Rai KR. Pulmonary complications in chronic lymphocytic leukemia. Cancer 2003; 98: 1912-7.
 
28.
Chen AL, Janko E, Pitman MB, Chebib I. Clinical, cytologic, and immunohistochemical features of sarcomas involving body cavity fluids. Cancer Cytopathol 2019; 127: 778-84.
 
29.
Maskell NA, Butland RJ. BTS guidelines for the investigation of a unilateral pleural effusion in adults. Thorax 2003; 58: ii8-17.
 
30.
Gunluoglu G, Olcmen A, Gunluoglu MZ, et al. Long-term outcome of patients with undiagnosed pleural effusion. Arch Bronconeumol 2015; 51: 632-6.
 
31.
Janssen JP. Why you do or do not need thoracoscopy. Eur Respir Rev 2010; 19: 213-6.
 
32.
Wrightson JM, Davies HE. Outcome of patients with nonspecific pleuritis at thoracoscopy. Curr Opin Pulm Med 2011; 17: 242-6.
 
33.
Shaw M, Collins BF, Ho LA, Raghu G. Rheumatoid arthritis- associated lung disease. Eur Respir Rev 2015; 24: 1-16.
 
34.
Gaensler EA. ‘Idiopathic’ pleural effusion. N Engl J Med 1970; 283: 816-7.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top